Sulbactam reduces the minimum inhibitory concentrations (MICs) of Cefoperazone by 4-fold.

Therapeutic indications:

  • Respiratory tract infections (upper and lower)
  • Urinary tract infections
  • Peritonitis, cholecystitis, cholangitis, and other intra-abdominal infections
  • Septicemia
  • Meningitis
  • Skin and soft tissue infections
  • Bone and joint infections
  • Pelvic inflammatory disease, endometritis, gonorrhoea, and other infections of the genital tract
  • Duodenal Ulcer Disease in Adults

Sulbactam reduces the minimum inhibitory concentrations (MICs) of Cefoperazone by 4-fold.


2:1 ratio of CZONE-S results in longer T>MIC, resulting in greater kill ratio.


Empirical Cefoperazone-Sulbactam monotherapy could be a useful adjunct to surgical intervention for intra-abdominal infections


Daily Dosage: